top of page

PUBLICATIONs

tumor burden IV vs Hyd 28 days.png

140. “Systematic screening of Metal-Organic Frameworks for enhanced drug delivery in metastatic pancreatic cancer therapy”

...

...

STM fig.png

139. “Nano-navigated macrophages: piercing the hepatic inflammation-fibrosis-cancer axis”

...

Alazne Moreno-Lanceta, E.R. Edelman, Joao Conde* and P. Melgar-Lesmes*

Figure 4 IHC (rev 7)-01.png

138. “Traceless release of a potent BET inhibitor enables targeted prostate cancer therapy”

...

...

Fig 1 nanoAI.png

137. “Accelerating discoveries in cancer nanomedicine using AI”

...

C. Guan, Bárbara B. Mendes, João Conniot, A.L. Dias, L. Hammad, T. Thambi, R. Langer*, T. Rodrigues*, João Conde* and C. de la Fuente-Nunez*

Fig 4 Nano Letters.png

136. “Biomimetic ghost nanomedicine-based optotheranostics for cancer”

...

R. Prasad*, V.G.S.S. Jyothi, N. Kommineni, R.T Bulusu, Bárbara B. Mendes and João Conde*

GBD 2021 Forecasting Capstone Conde.png

135. “Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study”

...

João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

Figure 1.png

134. “Triterpenoid saponin-based supramolecular host-guest injectable hydrogels inhibit the growth of melanoma via ROS-mediated apoptosis”

...

R. Mathiyalagan, M. Murugesan, Z.M. Ramadhania, J. Nahar, P. Manivasagan, E-S. Jang, D.C. Yang,
João Conde* and T. Thambi*

mRNA vaccines - MOA.png

133. “Industrial production of mRNA vaccines: challenges and opportunities”

...

João Pais, João Conde* and J. Pereira*

Fig 2 voices of biomed eng_Conde.png

132. “Voices of Biomedical Engineering: The importance of collaborative research in solving global healthcare challenges”

...

R. Prasad*, A. Ghosh, V. Patel, B. Peng, Bárbara B. Mendes, E.H.A. Win, L.G. Delogu, J.Y. Wong, K.J. Pische, J. Bellare, A. Bar-Shir, A.S. Thakor, W.J. Parak, Z.M. Bhujwalla, Y.S. Zhang, N. Kommineni, V. Rotello, W. Cai, T. Lammers, T.W. Odom, G. Padmanaban, D. Peer, J.F. Lovell, R. Srivastava*, R. Langer and João Conde*

GBD Risk factors Conde 2024.png

131. “Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021”

...

João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

Fig 6 Gene Panc.png

130. “In vivo nanomicelles modulate key intratumoral and metastatic genomic signalling pathways in pancreatic cancer”

...

...

AFM review.png

129. “Atomic force microscopy at the service of nanobiomedicine: Recent progress in the study of cancer and neurodegenerative diseases”

...

F.S. Ruggeri*, K. Lim, G.Nisini, V.S. Pokrovsky, João Conde and C. Marcuello*

metastatic cancer nanovaccine.png

128. “Bioengineered metastatic cancer nanovaccine with a TLR7/8 agonist for needle-free intranasal immunization”

...

J.M. Jung, M.S. Lee, Y.K. Seo, J.E. Lee, S.Y. Lim, D.H. Kim, S.Y. Lyu, C. Park, B.D. Kim, J.H. Shin, J.H. Lee, P. Liu, J. Jung, João Conde, T. Thambi, J.H. Jeong and D.S. Lee

1.png

127. “Has the epidemiological transition occurred in children? Fifty years from Omran’s “Epidemiologic Transition”

...

João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

Sem título5.png

126. “Burden of diseases and injuries attributable to risk factors in the European Union (EU-28) in 2019: a systematic analysis for the Global Burden of Disease Study 2019”

...

João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

Sem título_edited.jpg

125. “Electric field-responsive gold nanoantennas for the induction of a locoregional tumor pH change using electrolytic ablation therapy”

...

A. Joe, P. Manivasagan, J.K. Park, H-W. Han, S-H. Seo, T. Thambi, V.H.G. Phan, S.A. Kang, João Conde* and E-S. Jang*

Sem título.png

124. “The state of health in the European Union (EU-27) in 2019: A systematic analysis for the Global Burden of Disease Study 2019

...

João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

Sem título_edited.jpg

123. “The global burden of acute versus chronic care needs: Analysis of the Global Burden of Disease Study 2019”

...

João Conde & GBD 2019 Acute and Chronic Care Collaborators - Global Burden of Disease (GBD) Consortium

gr4_lrg Conde Lancet GBD2021.jpg

122. “Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021”

The Lancet (2024) - IF168.9

João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

Fig. 7.jpg

121. “Progress in nanomaterial-based synergistic photothermal-enhanced chemodynamic therapy in combating bacterial infections”

Progress in Materials Science (2024) - IF37.4

P. Manivasagan, T. Thambi, A. Joe, H-W. Han, S-H. Seo, Y.J. Jeon, João Conde*, E-S. Jang*

Sem título_edited.jpg

120. “Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021”

The Lancet (2024) - IF168.9

João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

Figure 2 (rev 7)-01.png

119. “Enhancing selectivity and overcoming tissue-specific toxicity in drug discovery: A novel BET inhibitor with targeted delivery for prostate cancer treatment”

Cancer Research (2024) - IF11.2

R. Traquete, E. Henderson, João Conde, S. Picaud, C. Tang, P. Filippakopoulos* and G.J.L. Bernardes*

Scheme 1 revised.png

118. “Preclinical assessment of an antibiotic-free cationic surfactant-based hydrogel for sexually and perinatal transmitted infections”

Matter, Cell Press (2023) - IF20.0 (just accepted)

R.D.A. Calado, Bárbara B. Mendes, João Conniot, João M.J.M. Ravasco, D. Sobral, C. Ferreira, R. Ferreira, J.C. Rodrigues, D. Santos, S. Duarte, L. Vieira, A.S. Inácio, H. Carrêlo, W.L.C. Vaz, J.P. Gomes, A. Nunes*, João Conde* and O.V. Vieira*

Lancet 2024 Conde GBD.jpg

117. “Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021”

The Lancet (2024) - IF168.9

João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

Fig 2 TIFF_edited.jpg

116. “Engineered nanomaterials for glioblastoma nanovaccination”

Nature Reviews Materials (2024) - IF76.7 (just accepted)

F. Haamedat, Bárbara B. Mendes, João Conniot, L.D. Di Filippo, M. Chorilli, A. Schroeder, João Conde* and F. Sousa*

GBD Conde Lancet Neuro 2024.jpg

115. “Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021”

The Lancet Neurology (2024) - Featured on Cover - IF48.0

João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

Conde Nature Nano 2024.png

114. “A large-scale machine learning analysis of inorganic nanoparticles in preclinical cancer research”

Nature Nanotechnology (2024) - IF40.5 (just accepted)

Bárbara B. Mendes, Z. Zhang, João Conniot, Diana P. Sousa, João M.J.M. Ravasco, L. Onweller, A. Lorenc, T. Rodrigues*, D. Reker* and João Conde* 

Conde and GBD Lancet 2024.jpg

113. “Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic”

The Lancet (2024) - IF168.9

João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

Figure 5.jpg

112. “Cathepsin B processing is required for the in vivo efficacy of albumin-drug conjugates”

Bioconjugate Chemistry (2024) - ACS Editors' Choice - IF6.1

B. Bernardim, João Conde, T. Hakala, J.B. Becher, M. Canzano, A.V. Vasco, T.P.J. Knowles, J. Cameron and G.J.L. Bernardes*

Fig 4_edited.jpg

111. “Biomimetic bright optotheranostics for metastasis monitoring and multimodal image-guided breast cancer therapeutics”

Journal of Controlled Release (2024) - IF11.5

R. Prasad*, B. Peng, Bárbara B. Mendes, H.I. Kilian, M. Gorain, H. Zhang, G.C. Kundu, J. Xia, J.F. Lovell and João Conde*

Fig 1 new.png

110. “Hydrogel microneedles: a theranostic toolbox for personalized nanomedicine”

Drug Delivery and Translational Research (2024) - Special Issue in honor of Prof. Patrick Couvreur - IF5.4

Catarina F. Martins, C. García-Astrain, João Conde and L. Liz-Marzán*

MOFs breast cancer.png

109. “A Fluorinated BODIPY-Based Zirconium Metal-Organic Framework for in vivo Enhanced Photodynamic Therapy”

Journal American Chemical Society (2024) - IF16.4

X. Chen, Bárbara B. Mendes, Y. Zhuang, João Conniot, S.M. Argandona, F. Melle, Diana P. Sousa, D. Perl, A. Chivu, H. K. Patra, W. Shepard, João Conde* and D. Fairen-Jimenez*

GBD 2023 JACC Conde.png

108. “Global Burden of Cardiovascular Diseases and Risks, 1990-2022”

Journal of the American College of Cardiology (2023) - IF27.6

João Conde & GBD Collaborators - Global Burden of Disease (GBD) Consortium

CSR 2023 Shu & Conde_edited.jpg

107. “Passive Nanoparticles for Organ-Selective Systemic Delivery: Design, Mechanism and Perspective”

Chemical Society Reviews (2023) - IF 46.2

L. Fu, Y. Zhang, R.A. Farokhzad, Bárbara B. Mendes, João Conde and J. Shi*

Scheme 1 rev.png

106. “Bioinspired and biomimetic cancer cell-membrane derived nanovesicles for preclinical tumor-targeted nanotheranostics”

Cell Reports Physical Science (2023) - IF 8.9

Rajendra Prasad*, Bárbara B. Mendes, M. Gorain, G.C. Kundu, N. Gupta, B. Peng, E.H.A. Win, Q. He and João Conde*

Fig 1 new.png

105. “Conjugated Nanoparticles for Solid Tumor Theranostics: Unraveling the Interplay of Known and Unknown Factors”

ACS Omega (2023) - IF 6.4

V.P. Chavda, P.C. Balar, L.V. Nalla, R. Bezbaruah, N.R. Gogoi, S.N.R. Gajula, B. Peng, A.S. Meena, João Conde, R. Prasad*

Figure 1A mRNA paper_JConde.png

104. “Intratumoural Delivery of mRNA Loaded on a Cationic Hyper-Branched Cyclodextrin-Based Polymer Induced an Anti-Tumour Immunological Response in Melanoma”

Cancers (2023) - IF6.6

F. Trotta, M. Mahmoudian, P. Zakeri-Milani, C. Cecone, K.J. Ishii, T. Hayashi, João Conde, A. Matencio and Y.K. Monfared

biosensor final.png

103. “Evolution of CRISPR-enabled biosensors for amplification-free nucleic acid detection”

Trends in Biotechnology (2023) - IF21.9

Sepehr Talebian*, Fariba Dehghani, Paul S. Weiss and João Conde*

ACS review Fig1.png

102. “Engineered Liposomes in Interventional Theranostics of Solid Tumors”

ACS Biomaterials Science & Engineering (2023) - Featured on Cover - IF5.8

N. Kommineni, R. Chaudhari, João Conde, S. Tamburaci, B. Cecen, P. Chandra, R. Prasad

Figure 4.jpeg

101. “A Receptor-mediated Landscape of Druggable and Targeted Nanomaterials for Gliomas”

Materials Today Bio (2023) - IF10.8

L.D.D Filippo, S.G. Carvalho, J.L. Duarte, M.T. Luiz, J.A.P. Dutra, G.A. Paula, M. Chorilli and João Conde*

Figure.tif

100. “Highlight: Biomimetic hydrogel supporting baths as an alternative to initiate and maintain breast tumor-derived organoids culture”

MedComm - Biomaterials and Applications (2023)

Jhenifer Oliveira, Mariana Pereira, Bárbara Mendes* and João Conde*

Conde exosomes 2023

99. “Bioengineered exosome membrane camouflaged-abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine”

Military Medical Research (2023) - IF34.9

D. Lopes, J. Lopes, M. Pereira-Silva, Diana Peixoto, N. Rabiee, F. Veiga, O. Moradi, Z.H. Guo, X.D. Wang, João Conde, P. Makvandi and A.C. Paiva-Santos

Sem título.png

98. “mRNA therapy at the convergence of genetics and nanomedicine”

Nature Nanotechnology (2023) - IF40.5

João Conde*, Robert Langer* and José Rueff*

Conde Nature Materials 2023.png

97. “Hydrogels for RNA delivery”
 

Nature Materials (2023) - Featured on Cover - IF47.6

Ruibo Zhong, Sepehr Talebian, Bárbara B. Mendes, Gordon Wallace, Robert Langer, João Conde* and Jinjun Shi*

Conde Advanced Science - 2023_edited.jpg

96. “Biopolymeric coatings for local release of therapeutics from biomedical implants”

Advanced Science (2023) - IF17.5

S. Talebian, Bárbara Mendes, João Conniot, S. Farajikhah, F. Dehghani, Z. Li, D. Bitoque, G. Silva, S. Naficy, João Conde* and G.G. Wallace*

Sem título.png

95. “Exosome Membrane-Coated Nanosystems: Exploring Biomedical Applications in Cancer Diagnosis and Therapy”

Matter, Cell Press (2023) - IF20.0

M. Shao, D. Lopes, J. Lopes, S. Yousefias, A. Macário-Soares, Diana Peixoto, I. Ferreira-Faria, F. Veiga, João Conde, Y. Huang,  X. Chen, A.C. Paiva-Santos and P. Makvandi

Conde Nat Rev Bioeng 2022.png

94. “Technological challenges of biomembrane-coated top-down cancer nanotherapy”

Nature Reviews Bioengineering (2023)

João M.J.M. Ravasco, A.C. Paiva-Santos* and João Conde*

Figure 1.png

93. “Using gold-nanobeacons as a theranostic technique to recognize, detect and inhibit specific nucleic acids”

STAR Protocols, Cell Press (2022)

Diana P. Sousa and João Conde*

TOC.png

92. “Magnetite and bismuth sulfide Janus heterostructures as radiosensitizers for in vivo enhanced radiotherapy in breast cancer”

Biomaterials Advances (2022) - IF8.4

H. Nosrati, M. Ghaffarlou, M. Salehiabar, N. Mousazadeh,F. Abhari, M. Barsbay, Y.N. Ertas, H. Rashidzadeh, A. Mohammadi, L. Nasehi, H. Rezaeejam, S. Davaran, A. Ramazani*, João Conde* and H.
Danafar*

Conde et al GBD Lancet.png

91. “The global burden of cancer attributable to risk factors, 2010–2019: a systematic analysis for the Global Burden of Disease Study 2019”

The Lancet (2022) - IF202.7

João Conde & GBD 2019 Cancer Risk Factors Collaborators - Global Burden of Disease (GBD) Consortium

TOC.png

90. “Nucleic acid-based therapy for brain cancer: Challenges and strategies”

Journal of Controlled Release (2022) - VSI: Brain Targeting Issue - IF11.5

Z. Zhang, João Conniot, Joana Amorim, Y. Jin, R. Prasad, X. Yan*, K. Fan* and João Conde*

Figure 2.png

89. “Gold nanoconjugates for miRNA modulation in cancer therapy: from miRNA silencing to miRNA mimics”

ACS Materials Au (2022) - Featured on Cover - Rising Stars Issue & Editors´ choice

Diana P. Sousa and João Conde*

Sem título.png

88. “Macrophage cell membrane-cloaked nanoplatforms in biomedical applications”

Small Methods (2022) - IF15.4

J. Lopes, D. Lopes, M. Pereira-Silva, D. Peixoto, F. Veiga, M.R. Hamblin, João Conde, C. Corbo, E.N. Zare, M. Ashrafizadeh, F.R. Tay, C. Chen, X. Wang, P. Makvandi and A.C. Santos

Lancet gastro Conde GBD 2022.png

87. “Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019”

The Lancet Gastroenterology & Hepatology (2022) - IF45.0

João Conde & GBD 2019 Colorectal Cancer Collaborators - Global Burden of Disease (GBD) Consortium

PrimeView Nat Rev Met Primers.png

86. “PrimeView - Nanodelivery of nucleic acids”
 

Bárbara B. Mendes, João Conniot, A. Avital, D. Yao, X. Jiang, X. Zhou, N. Sharf-Pauker, Y. Xiao, O. Adir, H. Liang*, J. Shi*, A. Schroeder* and João Conde*

Conde et al Nat Rev Met Primers.png

86. “Nanodelivery of nucleic acids”
 

Bárbara B. Mendes, João Conniot, A. Avital, D. Yao, X. Jiang, X. Zhou, N. Sharf-Pauker, Y. Xiao, O. Adir, H. Liang*, J. Shi*, A. Schroeder* and João Conde*

GBD Lancet Child Health Conde 2022.png

85. “Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019”

The Lancet Child & Adolescent Health (2022) - Featured on Cover - IF37.7

João Conde & GBD 2019 Collaborators - Global Burden of Disease (GBD) Consortium

Figure 1.tif

84. “Bioinspired Soft Nanovesicles as Site-Selective Imaging and Targeted Therapies for Cancer”
 

WIREs Nanomedicine & Nanobiotechnology (2022) - Featured on COVER - IF9.4

Rajendra Prasad* and João Conde*

The lancet oncology Conde GBD 2021.png

83. “The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019”
 

The Lancet Oncology (2021) - Featured on COVER - IF54.4

João Conde & GBD 2019 Adolescent and Young Adult Cancer Collaborators - Global Burden of Disease (GBD) Consortium

TOC AHM.png

82. “Prodrug polymeric nanoconjugates encapsulating gold nanoparticles for enhanced X-Ray radiation therapy in breast cancer”
 

Advanced Healthcare Materials (2021) - Rising Star Issue - Featured on COVER - IF11.1

H. Nosrati, F. Seidi, A. Hosseinmirzaei, N. Mousazadeh, A. Mohammadi, Mo. Ghaffarlou, H. Danafar, João Conde* and Ali Sharafi*

TOC.png

81. “Controlled delivery of gold nanoparticle-coupled miRNA therapeutics via an injectable self-healing hydrogel”
 

Nanoscale (2021) Featured on COVER - IF8.3

C.F.T. van der Ven, M.W. Tibbitt, João Conde, A. van Mil, J. Hjortnaes, P.A.F.M. Doevendans, J.P.G. Sluijter, E. Aikawa and Robert Langer

GBD 2019 JAMA ONCOLOGY Conde.png

80. “Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019”

JAMA Oncology (2021) - IF33.0

João Conde & GBD 2019 Cancer Collaborators - Global Burden of Disease (GBD) Consortium

Machine learning for next generation nanotechnology in healthcare.png

79. “Machine learning for next generation nanotechnology in healthcare”

 

Matter, Cell Press (2021) - IF20.0

A. Lorenc, Bárbara B. Mendes, João Conniot, Diana P. Sousa, João Conde*, T. Rodrigues*

Figure5.png

78. “Facts and Figures on Materials Science and Nanotechnology Progress and Investment”
 

ACS Nano (2021) Featured on COVER - IF18.0

Sepehr Talebian, Tiago Rodrigues, José das Neves, Bruno Sarmento*, Robert Langer* and João Conde*

gr3_lrg GBD Lancet.jpg

77. “Global, regional, and national progress toward Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019”

The Lancet (2021) Featured on COVER - IF202.7

João Conde & GBD 2019 Under-5 Mortality Collaborators - Global Burden of Disease (GBD) Consortium

Figure 1.jpeg

76. “Nanomedicine-based strategies to target and modulate the tumor microenvironment”
 

Trends in Cancer (2021) Featured on COVER - IF19.2

Bárbara B. Mendes, Diana P. Sousa, João Conniot and João Conde*

hydrogels brain cancer.png

75. “Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression”
 

ACS Central Science (2021) Featured on COVER - IF18.7

João Conde, R.A. Pumroy, C. Baker, T. Rodrigues, (...), F. Corzana, V.A. Morais, C.C. Faria, T. Carvalho, P. Filippakopoulos, B. Snijder, N.L. Barbosa-Morais, V.Y. Moiseenkova-Bell, G.J.L. Bernardes

se0c02312_0001.jpeg

74. “CRISPR Systems for COVID-19 Diagnosis”

 

ACS Sensors (2021) Featured on COVER - IF9.6

H. Rahimi, M. Salehiabar, M. Barsbay, M. Ghaffarlou, T. Kavetskyy, A. Sharafi, S. Davaran, Subhash C. Chauhan, H. Danafar, S. Kaboli, H. Nosrati, M.M. Yallapu, and João Conde*

TOC.jpg

73. “Ultrahigh penetration and retention of graphene quantum dot mesoporous silica nanohybrids for image guided tumor regression”
 

ACS Applied Bio Materials (2021) Featured on COVER - IF3.3

R. Prasad*, N.K. Jain, A.S. Yadav, M. Jadhav, N.N.V. Radharani, M. Gorain, G.C. Kundu, João Conde*, R. Srivastava*

Sem%20T%C3%ADtulo_edited.png

72. “Osteogenic Differentiation of Human Mesenchymal Stem Cells by the Single Action of Luminescent Polyurea Oxide Biodendrimers”
 

ACS Applied Bio Materials (2020) - IF3.3

Rita F. Pires, Joao Conde* and Vasco D.B. Bonifacio*

Figure 3.tif

71. “Revisiting Gene Delivery to the Brain: Silencing and Editing”
(2021 Biomaterials Science Emerging Investigators Issue)
 

Biomaterials Science (2020) - CRISPR Biomaterials Issue - Featured on COVER - IF7.6

João Conniot, Sepehr Talebian, Susana Simões, Lino Ferreira*, João Conde*

JConde.JPG

70. “Swallowing the doctor”: an interview with João Conde about the future of nanomedicine”
 

Communications Biology (2020) - IF6.5

João Conde*

Untitled.png

69. “Biomimetic cancer cell membrane coated-nanosystems as next-generation cancer therapies”
 

Expert Opinion on Drug Delivery (2020) - IF8.1

M. Pereira-Silva, A.C. Santos, João Conde, C. Hoskins, A. Concheiro, C. Alvarez-Lorenzo, F. Veiga

Figure Matter JConde (2).jpg

68. “Why Go NANO on COVID-19 pandemic?”

 

Matter, Cell Press (2020) - IF20.0

Sepehr Talebian and João Conde*

Nanotechnology-based disinfectants and s

67. “Nanotechnology-based disinfectants and sensors for SARS-CoV-2”

 

Nature Nanotechnology (2020) - COVID-19 Special Issue - Featured on COVER - IF40.5

S. Talebian, G.G. Wallace, A. Schroeder*, F. Stellacci* and João Conde*

anie202008012-fig-0001-m.jpg

66. “Tetrazine carbon nanotubes for pretargeted in vivo ‘click-to-release’ bioorthogonal imaging” (VIP paper)
 

Angewandte Chemie Int. Ed. (2020) Featured on COVER - IF16.8

H. Li, João Conde, A. Guerreiro, G.J.L. Bernardes

Localized Nanotheranostics.png

65. “Localized Nanotheranostics: Recent developments in Cancer Nanomedicine”
 

Materials Today Advances (2020) - IF9.9

R. Prasad, N.K. Jain, João Conde*, R. Srivastava

Platinum-triggered Bioorthogonal Decagin

64. “Platinum-triggered Bond-cleavage of Pentynoyl amide and N-propargyl handles for Drug-Activation”
 

Journal American Chemical Society (2020) Featured on COVER - IF16.4

B.L. Oliveira, B.J. Stenton, Unnikrishnan V.B., C.R. Almeida, João Conde, M. Negrão, F.S.S. Schneider, C. Cordeiro, M.G. Ferreira, G.F. Caramori, J.B Domingos, R. Fior and G.J.L. Bernardes

Figure 1 new2.tif

63. “Stepwise Assembly of Multimode Liposomal Nanotheranostic Agent for Targeted In Vivo Bioimaging and NIR Light Mediated Cancer Therapy”
 

Communications Biology (2020) - IF6.5

R. Prasad, N.K. Jain, A.S. Yadav, D.S. Chauhan, J. Devrukhkar, M.K. Kumawat, S. Shinde, M. Gorain, A.S. Thakor, G.C. Kundu, João Conde*, R. Srivastava*

Figure 1.tif

62. “Above and beyond Cancer Therapy: translating biomaterials into clinics”
 

Trends in Cancer (2020) - IF19.2

João Conde*

adhm201901101-fig-0001-m.jpg

61. “Prolonged local in vivo delivery of stimuli-responsive nanogels that rapidly release doxorubicin in triple-negative breast cancer cells”
 

Advanced Healthcare Materials (2020) Featured on COVER - IF11.1

Y. Zhang, P. Dosta, João Conde, N. Oliva, M. Wang and N. Artzi

Allosteric%20Antagonist%20Modulation%20o

60. “Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression”

Cell Sneak Peek (2019) - IF41.6

C. Baker*, T. Rodrigues*, R.A. Pumroy*, João Conde*, D. Picard, M.C. Marques, B.P. de Almeida, A. Samanta, F. Sieglitz, M. Langini, M. Remke, R. Roque, F. Corzana, C.C. Faria, T. Carvalho, N.L. Barbosa-Morais, V.Y. Moiseenkova-Bell, G.J.L. Bernardes

Cisplatin-Triggered Bioorthogonal Decagi

59. “Cisplatin-Triggered Bioorthogonal Decaging of Amide Bonds for Targeted-Drug Activation in vivo”
 

ChemRxiv. Preprint (2019)

B. Stenton, B. Oliveira, João Conde, M. Negrão, M. Godinho Ferreira, R. Fior, G. Bernardes

Oral pH sensitive Nanoprobes for Helicob

58. “Oral pH sensitive GNS@ab Nanoprobes for targeted therapy of Helicobacter Pylori without disturbance gut microbiome”
 

Nanomedicine: Nanotechnology, Biology and Medicine (2019) - IF6.5

X. Zhi, Y. Liu, L. Lin, M. Yang, L. Zhang, L. Zhang, Y. Liu, G. Alfranca, L. Ma, Q. Zhang, H. Fu, João Conde, X. Di, J. Ni, J. Song, D. Cui

Scheme 1.png

57. “Gastric parietal cell and Intestinal goblet cell secretion: a novel cell-mediated in vivo nanoparticle clearance pathway enhanced with diarrhea via Chinese Herbs”

Nanoscale Research Letters (2019) - IF5.4

Y. Liu, K. Liu, M. Yang, Y. Han, Q. Zhang, João Conde, Y. Yang, Y. Han, G. Alfranca, Y. Wang, J. Song, Y. Zhang, J. Ni, J.M. de la Fuente, D. Cui

systemic local_edited.png

56. “Biopolymers for anti-tumor implantable drug delivery systems: Recent advances and future outlook”
 

Advanced Materials (2018) - IF32.1

S. Talebian, S. Wadeb, J. Foroughi, K. L. Vineb, A. Dolatshahi-pirouz, M. Mehrali, João Conde, G. Wallace
 

glioma.png

55. “Ferritin nanocarrier traverses the blood brain barrier and kills glioma”
 

ACS Nano (2018) - IF18.0

K. Fan, X. Jia, M. Zhou, João Conde, J. He, J. Tian, X. Yan
 

Nanoparticle-antagomiR based targeting o

54. “Nanoparticle-antagomiR based targeting of miR-31 to induce osterix and osteocalcin expression in mesenchymal stem cells”
 

PLOS ONE (2018) - IF3.7

M. McCully, João Conde, P.V. Baptista, M. Mullin, M.J. Dalby, C.C. Berry

Plasmonic%20gold%20nanoparticles%20fungi

53. “Plasmonic gold nanoparticles for detection of fungi and human cutaneous fungal infections”
 

Analytical Bioanalytical Chemistry (2017). Featured on COVER - IF3.3

T. Sojinrin, João Conde*, K. Liu, J. Curtin, H.J. Byrne H, D. Cui, F. Tian*

Figure 1.png

52. “Smart NIR linear and nonlinear optical nanomaterials for cancer theranostics: prospects in photomedicine”
 

Progress in Materials Science (2017) - IF48.2

T.M. Liu*, João Conde*, T. Lipiński, A. Bednarkiewicz and C.C. Huang*

fullerene.jpg

51. “Fullerene: Biomedical Engineers Get to Revisit an Old Friend”

 

Materials Today (2017) - IF31

S. Goodarzi, T. Da Ros, João Conde, F. Sefat and M. Mozafari

Conspectus Accounts Conde.png

50. “Designing Hydrogels for On-Demand Therapy”

 

Accounts of Chemical Research (2017) - IF24.5

N. Oliva, João Conde, K. Wang and N. Artzi

Local microRNA delivery targets Palladin

49. “Local microRNA delivery targets Palladin and prevents metastatic breast cancer”
 

Nature Communications (2016) - IF17.7

A. Gilam, João Conde, D. Weissglas-Volkov, N. Oliva, E. Friedman, N. Artzi and N. Shomron

Epigenetics paper JC1_edited.png

48. “Chiral Antioxidant-based Gold Nanoclusters Reprogram DNA Epigenetic Patterns”
 

Scientific Reports (2016) - IF5.1

Y. Ma, H. Fu, C. Zhang, S. Cheng, J. Gao, Z. Wang, W. Jin*, João Conde* and D. Cui*

Gold Nanostars for efficient In Vitro an

47. “Gold Nanostars for efficient in Vitro and in Vivo Real-Time SERS Detection and Drug Delivery via Plasmonic-Tunable Raman/FTIR Imaging”
 

Biomaterials (2016) - IF15.3

F. Tian, João Conde*, C. Bao, Y. Chen, J. Curtin and D. Cui

Hydrogel-based Local Triple-Combination

46. “Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model”

Nature Materials (2016). Highlighted in Science Translational Medicine and Science Bulletin - IF47.6

João Conde*, N. Oliva, Y. Zhang and N. Artzi*

Revisiting the classification of NIR abs

45. “Revisiting the classification of NIR-absorbing/emitting nanomaterials for in vivo bioapplications”
 

Nature Asia Materials (2016) - IF10.8

T.M. Liu*, João Conde*, T. Lipiński, A. Bednarkiewicz and C.C. Huang*

Biomaterials for Metastasis.png

44. “Biomaterials for Metastasis: Bridging the Gap between Basic and Translational Research”
 

Advanced Healthcare Materials (2016). VIP paper Featured on COVER - IF11.1

João Conde, N. Shomron and N. Artzi*

Figure 1.png

43. “Revisiting the ‘one material fits all’ rule for cancer nanotherapy”

 

Trends in Biotechnology (2016) - IF21.9

João Conde*, N. Oliva and N. Artzi*

Figure 2.png

42. “3D Hydrogel Scaffold Doped With 2D Graphene Materials For Biosensors And Bioelectronics”
 

Biosensors & Bioelectronics (2016) - IF12.5

H.S. Song, O.S. Kwon, J.H. Kim, João Conde* and N. Artzi*

Gold Nanoprisms Cancer Theranostic.png

41. “Gold Nanoprisms as a hybrid in vivo Cancer Theranostic platform for in situ Photoacoustic Imaging, Angiography and localized Hyperthermia”
 

Nano Research (2016) - IF10.3

C. Bao, João Conde, F. Pan, C. Li, C. Zhang, F. Tian, S. Liang, J.M. de la Fuente and D. Cui

Figure 1.png

40. “Dual-Color Emissive Upconversion Nanocapsules for Differential Cancer Bioimaging in vivo”
 

ACS Nano (2016) - IF18.0

O.S. Kwon, H.S. Song, João Conde, H. Kim, N. Artzi and J.H. Kim

Self-assembled RNA triple helix hydrogel

39. “Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment”
 

Nature Materials (2016). Highlighted in Science Translational Medicine - IF47.6

João Conde*, N. Oliva, M. Atilano, H.S. Song and N. Artzi*

Nanotheranostics.png

38. “EDITORIAL: Cancer Nanotheranostics - What have we learned so far?”

 

Frontiers in Chemistry (2015) - IF5.5

João Conde*, F. Tian, J.M. de la Fuente and P.V. Baptista

The Golden Age in Cancer Nanobiotechnolo

37. “The Golden Age in Cancer Nanobiotechnology: Quo vadis?”

 

Frontiers in Bioengineering and Biotechnology (2015) - IF6.1

João Conde*

RNAi nanomaterials targeting immune cell

36. “RNAi nanomaterials targeting immune cells as an anti-tumor therapy: the missing link in cancer treatment?”

Materials Today (2015) - IF26.9

João Conde*, C. Arnold, F. Tian and N. Artzi*

1.jpg

35. “Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis”
 

Scientific Reports (2015) - IF5.1

C. Bao, João Conde*, J. Curtin, N. Artzi, F. Tian and D. Cui

15 years on siRNA delivery beyond the St

34. “15 years on siRNA delivery: beyond the State-of-the-Art on inorganic nanoparticles for RNAi Therapeutics”
 

Nano Today (2015) - IF19.0

João Conde*, A. Ambrosone, Y. Hernandez, F. Tian, M. McCully, C.C. Berry, P.V. Baptista, C. Tortiglione and J.M. de la Fuente

Figure Nano Research 2.png

33. “Significance of the balance between intracellular glutathione and polyethylene glycol for successful release of small interfering RNA from gold nanoparticles”

Nano Research (2015) - IF10.3

M. McCully, Y. Hernandez, João Conde, P.V. Baptista, J.M. de la Fuente, A. Hursthouse, D. Stirling and C.C.Berry

Types of AuNPs_YH.jpg

32. “Gold Nanoparticle-siRNA Mediated Oncogene Knockdown at RNA and Protein level, with associated Gene effects”
 

Nanomedicine (Lond.) (2015) - IF6.1

H.W. Child, Y. Hernandez, João Conde, M. Mullin, P.V. Baptista, J.M. de la Fuente and C.C. Berry

Untitled.png

31. “Investigating the role of shape on the biological impact of gold nanoparticles in vitro”
 

Nanomedicine (Lond.) (2015) - IF6.1

F. Tian, M.J.D. Clift, A. Casey, P. del Pino, B. Pelaz, João Conde, H.J. Byrne, B. Rothen-Rutishauser, G. Estrada, J.M. de la Fuente and T. Stoeger

TOC.png

30. “Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to tumour-associated macrophages and cancer cells”

Advanced Functional Materials (2015). Featured on COVER - IF19.9

João Conde*, C. Bao, Y. Tan, D. Cui, E.R. Edelman, H.S. Azevedo, H.J. Byrne, N. Artzi and F. Tian*

POXylated dendrimers for drug delivery.p

29. “POxylated polyurea dendrimers: Smart core-shell vectors with IC50 lowering capacity”
 

Macromolecular Bioscience (2015) - IF5.9

R.B. Restani, João Conde, R.F. Pires, P. Martins, A.R. Fernandes, P.V. Baptista, V.D.B. Bonifácio and A. Aguiar-Ricardo

Figure 1.png

28. “RNAi-based glyconanoparticles trigger apoptotic pathways for in vitro and in vivo enhanced cancer-cell killing”
 

Nanoscale (2015) - IF8.3

João Conde, F. Tian, Y. Hernandez, C. Bao, P.V. Baptista, D. Cui, T. Stoeger and J.M. de la Fuente

beacons.png

27. “The next generation of smart gold nanobeacons: nanotheranostics is ready for prime-time”
 

Nanomedicine (Lond.) (2015) - IF6.1

João Conde* & N. Artzi*

Figure 2.png

26. “Personalizing biomaterials for precision nanomedicine in light of local tissue microenvironment”
 

Advanced Healthcare Materials (2015). Featured on COVER - IF11.1

N. Oliva, S. Unterman, Y. Zhang, João Conde, H.S. Song and N. Artzi

drug%20gold%20nanobeacons%20hydrogel%20c

25. “Implantable hydrogel embedded dark-gold nanoswitch as a theranostics probe to sense and overcome cancer multidrug resistance”

PNAS (2015). Highlighted in Nature Reviews Drug Discovery - IF10.7

João Conde*, N. Oliva and N. Artzi*

Are RNAi and miRNA therapeutics truly de

24. “Are RNAi and miRNA therapeutics truly dead?”

 

Trends in Biotechnology (2015) - IF21.9

João Conde* & N. Artzi*

microRNAs.png

23. “Target-Responsive DNA/RNA nanomaterials for microRNA sensing and inhibition: the jack-of-all-trades in cancer nanotheranostics?”
 

Advanced Drug Delivery Reviews (2015) - IF17.9

João Conde*, E.R. Edelman and N. Artzi

as.png

22. “Polyurea dendrimer for efficient cytosolic siRNA delivery”

 

RSC Advances (2014) - IF4.0

R.B. Restani, João Conde, P.V. Baptista, M.T. Cidade, A.M. Bragança, J. Morgado, I.J. Correia, A. Aguiar-Ricardo and V.D.B. Bonifácio

Figure 1 new.png

21. “A promising road with challenges: where gold nanoparticles are in translational research?”
 

Nanomedicine (Lond.) (2014) - IF6.1

C. Bao, João Conde, E. Polo, P. del Pino, M. Moros, P.V. Baptista, V. Grazu, D. Cui and J.M. de la Fuente

Figure 3.png

20. “Revisiting 30 years of Biofunctionalization and Surface Chemistry of Inorganic Nanoparticles for Nanomedicine”
 

Frontiers in Chemistry (2014) - IF5.5

João Conde*, J.T. Dias, V. Grazú*, M. Moros, P.V. Baptista and J.M. De la Fuente

Graphical abstract new.png

19. “Antibody-Drug Gold Nanoantennas with Raman spectroscopic fingerprints for in vivo tumour Theranostics”
 

Journal of Controlled Release (2014) - IF11.5

João Conde*, C. Bao, D. Cui, P.V. Baptista and F. Tian*

Figure%201.png

18. “A Gold-nanobeacon system for Gene therapy: evaluation of Genotoxicity, Cell toxicity and Proteome profiling analysis”
 

Nanotoxicology (2014) - IF5.9

João Conde, M. Larguinho, A. Cordeiro, L.R. Raposo, P.M. Costa,S. Santos, M.S. Diniz, A.R. Fernandes and P.V. Baptista

Figure%201.png

17. “Gold-Nanobeacons as a theranostic system for the detection and inhibition of specific genes”
 

Nature Protocols - Protocol Exchange (2013) - IF13.5

João Conde, J. Rosa and P.V. Baptista

Figure%201%20Frontiers_REVISED.png

16. “Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?”
 

Frontiers in Pharmacology (2013) - IF6.0

João Conde*, J.M. de la Fuente and P.V. Baptista

TOC.png

15. “In vivo tumour targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models”
 

Biomaterials (2013) - IF15.3

João Conde, F. Tian, Y. Hernández, C. Bao, D. Cui, K.P. Janssen, M.R. Ibarra, P.V. Baptista, T. Stoëger and J.M. de la Fuente

Figure%201%20new%20scheme.png

14. “Gold-Nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events”
 

Biomaterials (2013) - IF15.3

João Conde, J. Rosa, J.M. de la Fuente and P.V. Baptista

TOC.png

13. “Design of Multifunctional Gold Nanoparticles for in vitro and in vivo Gene Silencing”
 

ACS Nano (2012) - IF18.0

João Conde, A. Ambrosone, V. Sanz, Y. Hernández, V. Marchesano, F. Tian, H. Child, C.C. Berry, M.R. Ibarra, P.V. Baptista, C. Tortiglione and J.M. de la Fuente

Scheme%201.png

12. “Effect of PEG biofunctional spacers and TAT peptide on dsRNA loading on Gold Nanoparticles”
 

Journal of Nanoparticle Research (2012) - IF2.3

V. Sanz, João Conde, Y. Hernández, P.V. Baptista, M.R. Ibarra and J.M. de la Fuente

Untitled.png

11. “Modification of Plasmid DNA Topology by Histone-Mimetic Gold Nanoparticles”
 

Nanomedicine (Lond.) (2012) - IF6.1

João Conde, P.V. Baptista, Y. Hernández, V. Sanz and J.M. de la Fuente

Figure%201.png

10. “Gold-Nanobeacons for Real-Time Monitoring of RNA Synthesis”

 

Biosensors & Bioelectronics (2012) - IF12.5

J. Rosa & João Conde, J.M. de la Fuente, J.C. Lima and P.V. Baptista

Sem Título.png

9. “Genotoxic effects of occupational exposure to lead and influence of polymorphisms in genes involved in lead toxicokinetics and in DNA repair”

Environment International (2012) - IF13.3

J. García-Lestón, J. Roma-Torres, M. Vilares, R.Pinto, J. Prista, J.P. Teixeira, O. Mayan, João Conde, M. Pingarilho, J.F. Gaspar, E. Pásaro, J. Méndez and B. Laffon

Fig1.png

8. “Noble Metal Nanoparticles for Biosensing Applications”

 

Sensors (Basel) (2012) - IF3.8

G. Doria, João Conde, B. Veigas, L. Giestas, C. Almeida, M. Assunção, J. Rosa and P.V. Baptista

Figure%2010.png

7. “Noble Metal Nanoparticles Applications in Cancer”

 

Journal of Drug Delivery (2012)

João Conde, G. Doria and P.V. Baptista

Scheme%20Review%20Photonics.png

6. “Nanophotonics for Molecular Diagnostics and Therapy Applications”

 

International Journal Photoenergy (2012) - IF2.5

João Conde, J. Rosa, J.C. Lima and P.V. Baptista

Baptista%20etal_Alloy%20metal%20nanopart

5. “Alloy Metal Nanoparticles for Multicolour Cancer Diagnostics”

 

Proceedings of SPIE (2011)

P.V. Baptista, G. Doria and João Conde

FIGURE%201.png

4. “In vitro Transcription and Translation Inhibition via DNA functionalized Gold Nanoparticles”
 

Nanotechnology (2010) - IF3.9

João Conde, J.M. de la Fuente and P.V. Baptista

Use%20of%20cyclodextrins%20as%20scavenge

3. “Use of Cyclodextrins as Scavengers of Inhibitory Photo-products in Light controlled in vitro Synthesis of RNA”
 

Journal of Photochemistry and Photobiology A: Chemistry (2010) - IF5.1

A. Vidal Pinheiro, João Conde, A.J. Parola, J.C. Lima and P.V. Baptista

Figure%2021.png

2. “RNA Quantification using Gold Nanoprobes - application to Cancer Diagnostics”
 

Journal of Nanobiotechnology (2010) - IF9.5

João Conde, J.M. de la Fuente and P.V. Baptista

Sem Título.png

1. “Association of common variants in Mismatch Repair Genes and Breast Cancer susceptibility: a Multigene study”
 

BMC Cancer (2009) - IF4.6

João Conde, S.N. Silva, A.P. Azevedo, V. Teixeira, J.E. Pina, J. Rueff and J.F. Gaspar

bottom of page